Research Journal of Pharmacy and Technology

The scientific prediction of the necessity to develop a new herbal medicine for the treatment of the bowel is based on the consumers’ need for affordable drugs with a pronounced anti-inflammatory effect that can be used for a long time with minimal addiction and side or undesirable effects.

The aim of our work is to provide marketing justification for the development of a new medicinal product based on medicinal herbal raw materials for the treatment of acute and chronic inflammatory bowel diseases in the capsule dosage form.

The methodology of the study is presented in the form of an algorithm containing the following steps: analysis of bowel diseases, etiology and symptomatology characteristics of the colitis, determination of common approaches to the treatment of acute and chronic colitis, formation of the groups of drugs list used in the treatment of colitis, marketing analysis of the State Register of Medicines of Ukraine , analysis of remedies on the basis of medicinal plant raw materials, highlighting the competitiveness components of new drugs.

The algorithm of marketing substantiation of the feasibility of development and introduction into production of a new medicinal product on a plant basis is developed, the components of competitiveness of a new medicinal product by groups are distinguished: pharmacotherapeutic, safety advantages, technological advantages, advantages of physical and economic accessibility.

Given the increase in the number of patients with acute and chronic colitis, conducted a study of the symptoms and principles of therapy of these diseases, conducted marketing study of medications market of Ukraine, it is advisable to develop a new drug based on medicinal herbs of complex action, which would have an antiflatulence, anti-inflammatory, regenerative effects, convenient dosage form, affordable price, long-term use, meet the needs of doctors and consumers.